Results 111 to 120 of about 547 (137)

Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine-Glycine-Aspartate) Strategies. [PDF]

Pharmaceuticals (Basel)
Bogdanović B, Fagret D, Ghezzi C, Montemagno C.   +3 more
europepmc   +1 more source

STK26 Promotes the Stabilization of ATF6 to Facilitate the Progression of Colorectal Cancer. [PDF]

Int J Mol Sci
Ding Y, Ren J, Hu C, Han J, Zhang J, Huang Z, Zhang Y, Wang W, Yu W, Shu Q, Li S.   +10 more
europepmc   +1 more source

Peptide Aptamer-Paclitaxel Conjugates for Tumor Targeted Therapy. [PDF]

Pharmaceutics
Shen X, Ma Y, Luo H, Abdullah R, Pan Y, Zhang Y, Zhong C, Zhang B, Zhang G.   +8 more
europepmc   +1 more source

KIF11 variants in familial exudative vitreoretinopathy leading to mTORC1 overactivation and impaired cell cycle progression. [PDF]

Hum Genomics
Liu M, Pan S, Dai E, Zhao R.
europepmc   +1 more source

Improved Positron Emission Tomography Quantification: Evaluation of a Maximum-Likelihood Scatter Scaling Algorithm. [PDF]

Diagnostics (Basel)
Overbeck N, Ahangari S, Conti M, Panin V, Azam A, Kurbegovic S, Kjær A, Højgaard L, Korsholm K, Fischer BM, Andersen FL, Andersen TL.   +11 more
europepmc   +1 more source

JAG modulates sepal flatness by regulating cell growth direction, interacts with AS2, and is antagonized by TCP24. [PDF]

Cell Rep
He X, Xu S, Singh Yadav A, Liu R, Zhou H, Xu Y, Xiang D, He Y, Xu J, Roeder AHK, Hong L.   +10 more
europepmc   +1 more source

Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer. [PDF]

J Zhejiang Univ Sci B
Fang J, Alhaskawi A, Dong Y, Cheng C, Xu Z, Tian J, Abdalbary SA, Lu H.   +7 more
europepmc   +1 more source

Recent trends in preparation and biomedical applications of iron oxide nanoparticles. [PDF]

J Nanobiotechnology
Meng YQ, Shi YN, Zhu YP, Liu YQ, Gu LW, Liu DD, Ma A, Xia F, Guo QY, Xu CC, Zhang JZ, Qiu C, Wang JG.   +12 more
europepmc   +1 more source

Ubiquitin D Promotes Lung Metastasis by Stabilizing MMP3 in Triple-Negative Breast Cancer. [PDF]

Research (Wash D C)
Xu R, Wu T, Li H, Ji S, Zhou Q, Peng Y, Zhao Q, Sun X, Liu P, Du W.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

68Ga-labeled HBED-CC Variant of uPAR Targeting Peptide AE105 Compared with 68Ga-NODAGA-AE105.

Anti-Cancer Agents in Medicinal Chemistry, 2019
AIMS The urokinase Plasminogen Activator Receptors (uPAR) over-expressed on tumor cells and their invasive microenvironment are clinically significant molecular targets for cancer research.
Kusum Vats, Rohit Sharma, Haladhar Dev Sarma, Drishty Satpati, A. Dash   +4 more
semanticscholar   +3 more sources